Damage occurs early in systemic vasculitis and is an index of outcome

被引:93
作者
Exley, AR
Carruthers, DM
Luqmani, RA
Kitas, GD
Gordon, C
Janssen, BA
Savage, COS
Bacon, PA
机构
[1] UNIV BIRMINGHAM,DEPT IMMUNOL,BIRMINGHAM VASCULITIS GRP,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND
[2] UNIV BIRMINGHAM,DEPT NEPHROL,BIRMINGHAM VASCULITIS GRP,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND
[3] UNIV EDINBURGH,DEPT RHEUMATOL,EDINBURGH,MIDLOTHIAN,SCOTLAND
来源
QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS | 1997年 / 90卷 / 06期
关键词
D O I
10.1093/qjmed/90.6.391
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Because death after acute systemic vasculitis is now uncommon, alternative measures of outcome are required. A significant component of patient morbidity is disease-related damage, which can be quantified by the Vasculitis Damage Index (64 items in 11 organ-based systems). We investigated serially the time-course of damage in 120 patients with systemic vasculitis, to determine the earliest indicators of outcome. High damage scores at 2 years after presentation were characteristic of fatal disease (OR 8.1-12.4). Significant damage occurred within 6 months of presentation, and was a feature of fatal disease. More damage occurred after presentation than after relapse. Lung and multi-system damage were early indicators of poor outcome in severe non-fatal disease. Damage occurs early in systemic vasculitis, and is an indicator of poor outcome. This novel observation, together with evidence of persistent subclinical disease activity and the high frequency of relapse, suggests a need for new treatment strategies. Analogy with the management of acute leukaemia suggests a strategy of early diagnosis and intensive induction of remission, with early escalation of treatment for resistant disease.
引用
收藏
页码:391 / 399
页数:9
相关论文
共 41 条
[1]  
AREND WP, 1990, ARTHRITIS RHEUM, V33, P1129
[2]  
BACON PA, 1995, CLIN EXP RHEUMATOL, V13, P275
[3]  
EVERITT BS, 1994, STAT METHODS MED INV, P197
[4]   Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides [J].
Exley, AR ;
Bacon, PA ;
Luqmani, RA ;
Kitas, GD ;
Gordon, C ;
Savage, COS ;
Adu, D .
ARTHRITIS AND RHEUMATISM, 1997, 40 (02) :371-380
[5]  
Exley AR, 1996, ARTHRITIS RHEUM, V39, P238
[6]  
EXLEY AR, 1996, SARCOIDOSIS VASC DIF, V13, P273
[7]   WEGENERS GRANULOMATOSIS - PROSPECTIVE CLINICAL AND THERAPEUTIC EXPERIENCE WITH 85 PATIENTS FOR 21 YEARS [J].
FAUCI, AS ;
HAYNES, BF ;
KATZ, P ;
WOLFF, SM .
ANNALS OF INTERNAL MEDICINE, 1983, 98 (01) :76-85
[8]  
FORTIN PR, 1995, J RHEUMATOL, V22, P2078
[9]  
GORDON M, 1993, Q J MED, V86, P779
[10]   Influence of the HLA-DRB1 locus on susceptibility and severity in rheumatoid arthritis Influence of the HLA-DRB1 locus on susceptibility and severity in rheumatoid arthritis [J].
Hall, FC ;
Weeks, DE ;
Camilleri, JP ;
Williams, LA ;
Amos, N ;
Darke, C ;
Gibson, K ;
Pile, K ;
Wordsworth, BP ;
Jessop, JD .
QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 1996, 89 (11) :821-829